SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers
Sarah Jannier, Natacha Entz‐Werlé(Hôpital d'Hautepierre)
Cited by 7
Related Papers
Prognostic Significance of Allelic Imbalance at the <i>c-kit</i> Gene Locus and c-kit Overexpression by Immunohistochemistry in Pediatric Osteosarcomas
|Journal of Clinical Oncology|2005|26
<i>KIT</i> gene in pediatric osteosarcomas: Could it be a new therapeutic target?
|International Journal of Cancer|2007|23
Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric H3.3-Mutated Gliomas Recreate the Patient Tumor Complexity
|Cancers|2019|22